These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12973073)
1. Should ultrasound criteria of the prostate be redefined to better evaluate when and where to biopsy. Vo T; Rifkin MD; Peters TL Ultrasound Q; 2001 Sep; 17(3):171-6. PubMed ID: 12973073 [TBL] [Abstract][Full Text] [Related]
2. The incidence of hyperechoic prostate cancer in transrectal ultrasound-guided biopsy specimens. Spajic B; Eupic H; Tomas D; Stimac G; Kruslin B; Kraus O Urology; 2007 Oct; 70(4):734-7. PubMed ID: 17991546 [TBL] [Abstract][Full Text] [Related]
5. Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer. Spencer JA; Alexander AA; Gomella L; Matteucci T; Goldberg BB Clin Radiol; 1994 Oct; 49(10):711-4. PubMed ID: 7955836 [TBL] [Abstract][Full Text] [Related]
6. Hypoehoic lesions on Transrectal Ultrasound and its correlation to Gleason grade in the diagnosis of Clinically Significant Prostate Cancer: A Prospective Study. Sharma M; Nerli RB; Nutalapati SH; Ghagane SC South Asian J Cancer; 2021 Sep; 10(3):155-160. PubMed ID: 34938677 [No Abstract] [Full Text] [Related]
7. Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer. Inahara M; Suzuki H; Nakamachi H; Kamiya N; Shimbo M; Komiya A; Ueda T; Ichikawa T; Akakura K; Ito H Int Urol Nephrol; 2004; 36(2):175-80. PubMed ID: 15368688 [TBL] [Abstract][Full Text] [Related]
8. Transrectal ultrasound guided biopsy for detecting prostate cancer: can random biopsies be reduced using the 4-dimensional technique? Abul FT; Arun N; Abu-Assi MA; Asbeutah AM Int Urol Nephrol; 2007; 39(2):517-24. PubMed ID: 17308874 [TBL] [Abstract][Full Text] [Related]
9. Comparison of systematic sextant and lesion directed biopsies in prostate cancer detection. Seltzer MA; Shinohara K; Bhargava V; Carroll PR; Presti JC Urol Oncol; 1996; 2(5):136-8. PubMed ID: 21224157 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mL. Fleshner NE; O'Sullivan M; Premdass C; Fair WR Urology; 1999 Feb; 53(2):356-8. PubMed ID: 9933054 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy. Ito K; Ichinose Y; Kubota Y; Imai K; Yamanaka H Int J Urol; 1997 Sep; 4(5):474-9. PubMed ID: 9354949 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of digital rectal examination, serum prostate-specific antigen, transrectal ultrasonography and systematic prostate biopsy for the detection of organ-confined prostate cancer. Gohji K; Okamoto M; Morisue K; Fujii A Int J Urol; 1995 May; 2(2):116-20. PubMed ID: 7553283 [TBL] [Abstract][Full Text] [Related]
13. The predictive efficacy of hypoechoic lesion in ultrasound for prostate cancer in Chinese people: five-year experience in a moderated 10-core transperineal prostate biopsy procedure. Yang T; Zhang L; Chen Y; Cai Y; Jiang H; Ding Q Oncotarget; 2017 Oct; 8(45):79433-79440. PubMed ID: 29108322 [TBL] [Abstract][Full Text] [Related]
14. [Role of ultrasonography-guided prostatic biopsy of hypoechoic areas associated with systematic biopsies in patients with normal and high PSA levels]. Scattoni V; Roscigno M; Raber M; Consonni P; Freschi M; Montorsi F; Pasta A; Colombo R; Nava L; Bua L; Rigatti P Arch Ital Urol Androl; 2002 Dec; 74(4):273-5. PubMed ID: 12508749 [TBL] [Abstract][Full Text] [Related]
15. Correlation of transrectal ultrasonographic findings with histo pathology in prostatic cancer. Ganie FA; Wanie MS; Ganie SA; Lone H; Gani M; Mir MF; Khan NA J Educ Health Promot; 2014; 3():38. PubMed ID: 25013831 [TBL] [Abstract][Full Text] [Related]
16. Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions. Loch T; Eppelmann U; Lehmann J; Wullich B; Loch A; Stöckle M World J Urol; 2004 Nov; 22(5):357-60. PubMed ID: 15672278 [TBL] [Abstract][Full Text] [Related]
17. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans. Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990 [TBL] [Abstract][Full Text] [Related]
18. Are hypoechoic lesions on transrectal ultrasonography a marker for clinically significant prostate cancer? Noh TI; Shin YS; Shim JS; Yoon JH; Kim JH; Bae JH; Moon du G; Park JY Korean J Urol; 2013 Oct; 54(10):666-70. PubMed ID: 24175039 [TBL] [Abstract][Full Text] [Related]
19. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. Garcia-Reyes K; Nguyen HG; Zagoria RJ; Shinohara K; Carroll PR; Behr SC; Westphalen AC J Urol; 2018 Mar; 199(3):699-705. PubMed ID: 28941918 [TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]